Boston Marriott Burlington Offers ''Meeting Bubble''
What is a meeting Bubble?Inspired by the sports teams working together in a bubble environment, The Boston Marriott Burlington is offering more flexible, creative ways to keep customers and their teams safe and connected during all phases of the pandemic.Details
Marshall's Auto Body Experts Helps Local Family
Marshall's Autobody Experts were featured on WCVB's "5 for Good" program for their generous support of a local family.Watch the video here.
Governor Announces Vaccine Timeline for all Residents
BOSTON — Today, the Baker-Polito Administration announced the timeline for all remaining residents to be eligible for a vaccine. The Administration also announced the weekly distribution of vaccine doses statewide for providers and a new $24.7 million investment in the Administration’s Vaccine Equity Initiative. Vaccine Eligibility Timeline Governor Baker today announced the dates that all remaining residents and certain worker groups will be eligible for a vaccine. The Commonwealth’s detailed timeline
Burlington Restaurants Participate in Dine Out Boston 2021
Dine Out Boston (formerly known as Restaurant Week Boston®) comes to Burlington March 14th - 28th. Enjoy some of the best food in the state while staying here in town! Check out our Participating Member Restaurants Here.
Lahey Hospital distributes more than $120,000 in grant funding to seven community organizations
Burlington, Mass. – Lahey Hospital & Medical Center, part of Beth Israel Lahey Health, announced today it is awarding over $120,000 in grant funding to seven community-based organizations. As part of an ongoing community benefits commitment, these grants will provide much needed funding for local organizations in support of their mission to meet their community’s needs. Of particular emphasis for the grant awards are programs and services that focus on food access, mental health, transportation, and
MilliporeSigma to Manufacture Next-Generation Biotherapeutics for Alteogen
Burlington, Massachusetts, February 25, 2021— MilliporeSigma, today announced an agreement with Alteogen, Inc., of South Korea, providing late-stage CDMO services through MilliporeSigma’s BioReliance® End-to-End Solutions. Alteogen selected MilliporeSigma to develop and produce recombinant biologics for the development and clinical evaluation of next-generation therapeutics of monoclonal antibody drugs. "There is growing demand for the subcutaneous route of administration, as it enables self-medication,
Governor Announces Plan for Continued Reopening
BOSTON — Today, the Baker-Polito Administration announced that Massachusetts would advance to Step 2 of Phase III of the state’s reopening plan on Monday, March 1, and also announced its plan to transition to Step 1 of Phase IV on Monday, March 22. With public health metrics continuing to trend in a positive direction, including drops in average daily COVID cases and hospitalizations, and vaccination rates continuing to increase, the Administration is taking steps to continue to reopen the Commonwealth’s
Northeastern-Burlington's David Luzzi Elected a National Academy of Inventors Fellow
David Luzzi, an academic leader in innovation for more than two decades, has been elected a fellow of the National Academy of Inventors for his work creating and facilitating inventions and improving universities as research partners. “It’s a great honor to be recognized,” says Luzzi, who is also the senior vice provost for research and helped lead the development of Northeastern’s Innovation Campus. “It’s also a credit to the founders of the NAI for recognizing that entrepreneurship and innovation
